NEUMORA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.69 USD | +0.21% |
|
+8.15% | -43.17% |
| 14/05 | Neumora Therapeutics Begins Phase 2 Study of Navacaprant in Bipolar Depression | MT |
| 14/05 | Neumora Therapeutics, Inc. Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 11.60 | 12.44 | 19.76 |
| Spread/Res. | -16.47% | -22.11% | -50.96% |
| Spread/Supp. | +8.15% | +8.15% | +5.90% |
| Support | 8.960 | 8.960 | 9.150 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- NMRA Stock
- Charts Neumora Therapeutics, Inc.